GPA
MLAB icon

Guidance Point Advisors’s Mesa Laboratories MLAB Stock Holding History

Guidance Point Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16
Closed -$4K – 276
2021
Q3 		$4K Buy
+16
New +$4.55K ﹤0.01% 355

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Guidance Point Advisors's MLAB Position: Q4 2021 in Review

Guidance Point Advisors sold out of Mesa Laboratories (MLAB) in Q4 2021, closing a stake of 16 shares — an estimated $4K sold.

Guidance Point Advisors first reported a position in MLAB in Q3 2021 and held it in 1 quarter. The position peaked at $4K in Q3 2021. 178 funds tracked by Wall St. Rank hold MLAB as of Q4 2021.

  • Guidance Point Advisors reported no remaining Mesa Laboratories position as of Q4 2021 after selling out during the quarter.
  • Guidance Point Advisors sold 16 Mesa Laboratories shares in Q4 2021, an estimated $4K.
  • Guidance Point Advisors first reported a position in Mesa Laboratories in Q3 2021 and held it in 1 quarter.
  • Guidance Point Advisors's Mesa Laboratories position peaked at $4K in Q3 2021.
  • 178 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2021.

Based on Guidance Point Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.